Homedelivery of provisions

Tender description

This Framework Agreement is awarded for the provision of a homecare delivery service for delivery of medicines to patients in their homes or other agreed designated delivery points. The service is divided into two (2) lots covering low-tech and mid-tech homecare delivery services. It includes the dispensing of prescriptions, delivery of medication and the supply of ancillary products, provision of nurse support for injection training and supply of and removal of sharps containers as required. This tender is for approximately 12 000 patients across NHS Scotland initially, resulting in approximately 53 000 deliveries p.a. The estimated value for the medicines to be delivered under this Framework Agreement is 60 000 000 GBP p.a. The Framework Agreement is awarded in two (2) lots, with each lot being awarded as a multi-supplier unranked framework to a maximum of eight (8) framework participants in each lot. Lot 1 is for a low-tech homecare delivery service to deliver a range of oral medicines (for HIV, Pulmonary Arterial Hypertension and Oncology). The service includes the dispensing of prescriptions and delivery of the medication along with ancillary products if required, to patients in their homes or other agreed designated delivery points and to supply and remove any associated sharps containers. It will be for approximately 2 500 patients across NHS Scotland initially, resulting in approximately 8 000 deliveries per annum. The number of patients and deliveries will vary through the duration of the Framework Agreement. The lot is awarded as an unranked multi-supplier framework to a maximum of eight (8) framework participants. The authority may add new or additional medicines into the lot, as and when required. Lot 2 is for mid-tech homecare delivery service to deliver a range of injectable medicines, the majority of which are in pre-filled syringes/pens. The medicines covered are: — etanercept, — methotrexate, — erythropoietin stimulating agents, — glatiramer acetate, — adalimumab, — epoprostenol and — iloprost. The service includes the dispensing of prescriptions, delivery of the medication whilst maintaining all required storage conditions, delivery of ancillary products as required, nurse support for injection training as required and the supply and removal of sharps containers. This lot will cover approximately 8 600 patients across NHS Scotland initially, resulting in approximately 45 000 deliveries per annum. The number of patients and deliveries will vary through the duration of the Framework Agreement. The lot is awarded as an unranked multi-supplier framework to a maximum of eight (8) framework participants. The authority may add new or additional medicines into the lot, as and when required.